Article Menu
-
Academic Editor
Myung-Ju Ahn
- Recommended Articles
- Related Info Link
-
More by Authors Links
- on DOAJ
- Beduk Esen, C. Selenge
- Celikarslan, S.
- Sezen, D.
- Selcukbiricik, F.
- Kaban, K.
- Kanitez, M.
- Yumuk, P. Fulden
- Molinas Mandel, N.
- Tabak, L.
- Cesur, E.
- Erus, S.
- Tanju, S.
- Dilege, S.
- Gumus, T.
- Atasoy, C.
- Demirkurek, C.
- Falay, O.
- Demirkol, M. Onur
- Bulutay, P.
- Firat, P.
- Selek, M.
- Duman, M.
- Mohammadipour, S.
- Oymak, S. Ezgi
- Kilic Durankus, N.
- Atagun, Y.
- Selek, U.
- on Google Scholar
- Beduk Esen, C. Selenge
- Celikarslan, S.
- Sezen, D.
- Selcukbiricik, F.
- Kaban, K.
- Kanitez, M.
- Yumuk, P. Fulden
- Molinas Mandel, N.
- Tabak, L.
- Cesur, E.
- Erus, S.
- Tanju, S.
- Dilege, S.
- Gumus, T.
- Atasoy, C.
- Demirkurek, C.
- Falay, O.
- Demirkol, M. Onur
- Bulutay, P.
- Firat, P.
- Selek, M.
- Duman, M.
- Mohammadipour, S.
- Oymak, S. Ezgi
- Kilic Durankus, N.
- Atagun, Y.
- Selek, U.
- on PubMed
- Beduk Esen, C. Selenge
- Celikarslan, S.
- Sezen, D.
- Selcukbiricik, F.
- Kaban, K.
- Kanitez, M.
- Yumuk, P. Fulden
- Molinas Mandel, N.
- Tabak, L.
- Cesur, E.
- Erus, S.
- Tanju, S.
- Dilege, S.
- Gumus, T.
- Atasoy, C.
- Demirkurek, C.
- Falay, O.
- Demirkol, M. Onur
- Bulutay, P.
- Firat, P.
- Selek, M.
- Duman, M.
- Mohammadipour, S.
- Oymak, S. Ezgi
- Kilic Durankus, N.
- Atagun, Y.
- Selek, U.
Need Help?
Order Article Reprints
Journal: Cancers, 2026
Volume: 18
Number: 2036
2036
Article:
Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes Analysis
Authors:
by
Caglayan Selenge Beduk Esen, Sukran Celikarslan, Duygu Sezen, Fatih Selcukbiricik, Kerim Kaban, Metin Kanitez, Perran Fulden Yumuk, Nil Molinas Mandel, Levent Tabak, Ezgi Cesur, Suat Erus, Serhan Tanju, Sukru Dilege, Terman Gumus, Cetin Atasoy, Cengiz Demirkurek, Okan Falay, Mehmet Onur Demirkol, Pinar Bulutay, Pinar Firat, Melis Selek, Merve Duman, Sepideh Mohammadipour, Saliha Ezgi Oymak, Nulifer Kilic Durankus, Yasemin Atagun and Ugur Selekadd
Show full author list
remove
Hide full author list
Link:
https://www.mdpi.com/2072-6694/18/13/2036
MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover
and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article
and designed to be complimentary to the journal.
Cite
Beduk Esen, C.S.; Celikarslan, S.; Sezen, D.; Selcukbiricik, F.; Kaban, K.; Kanitez, M.; Yumuk, P.F.; Molinas Mandel, N.; Tabak, L.; Cesur, E.; et al. Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes Analysis. Cancers 2026, 18, 2036. https://doi.org/10.3390/cancers18132036
Beduk Esen CS, Celikarslan S, Sezen D, Selcukbiricik F, Kaban K, Kanitez M, Yumuk PF, Molinas Mandel N, Tabak L, Cesur E, et al. Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes Analysis. Cancers. 2026; 18(13):2036. https://doi.org/10.3390/cancers18132036
Chicago/Turabian StyleBeduk Esen, Caglayan Selenge, Sukran Celikarslan, Duygu Sezen, Fatih Selcukbiricik, Kerim Kaban, Metin Kanitez, Perran Fulden Yumuk, Nil Molinas Mandel, Levent Tabak, Ezgi Cesur, and et al. 2026. "Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes Analysis" Cancers 18, no. 13: 2036. https://doi.org/10.3390/cancers18132036
APA StyleBeduk Esen, C. S., Celikarslan, S., Sezen, D., Selcukbiricik, F., Kaban, K., Kanitez, M., Yumuk, P. F., Molinas Mandel, N., Tabak, L., Cesur, E., Erus, S., Tanju, S., Dilege, S., Gumus, T., Atasoy, C., Demirkurek, C., Falay, O., Demirkol, M. O., Bulutay, P., ... Selek, U. (2026). Induction Chemoimmunotherapy Followed by Consolidative Hypofractionated Radiotherapy for Unresectable Locally Advanced NSCLC: A Real-World Outcomes Analysis. Cancers, 18(13), 2036. https://doi.org/10.3390/cancers18132036
